Deleted tweet detection is currently running at reduced capacity due to changes to the Twitter API. Some tweets that have been deleted by the tweet author may not be labeled as deleted in the PolitiTweet interface.

Showing page 4 of 105.

Profile Image

Teva Pharmaceuticals @TevaUSA

@CHAMANS63758645 Thank you. Please submit your Code of Conduct concern to the Teva Integrity Hotline for appropriate handling and response. https://t.co/sFlWFDLthg — PolitiTweet.org

Posted Nov. 16, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

It’s #GlobalBiosimilarsWeek, and we’re raising awareness for #biosimilars and the important role they play in expanding access to care in healthcare systems around the globe. Discover the magic of biosimilars here: https://t.co/XTWTahK4YL #TevaBiosimilarsUnlockingValue #TevaUSA https://t.co/eurEnGWjNi — PolitiTweet.org

Posted Nov. 15, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Today, our Head of Digital Health and Innovation, Manny Montalvo, spoke on a panel at #HLTH2022 to discuss the bright future ahead in the #digitalhealth and digital therapeutics space. Thank you to @GoldsackJen, @judbrewer, and Faisel Khan for an inspiring discussion. https://t.co/QtYg6hVjse — PolitiTweet.org

Posted Nov. 15, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

RT @Lucienneide: #digitaltherapeutics panel at #HLTH2022 with @TevaUSA - digital therapeutics can’t interfere with #hcp workflows and need… — PolitiTweet.org

Posted Nov. 15, 2022 Retweet
Profile Image

Teva Pharmaceuticals @TevaUSA

Proud to host Governor Parson and the delegation of Missouri Israel Trade & Investment Office, Missouri Department of Economic Development at Teva’s SLE's logistic center in Shoham to discuss our mission of striving to improve the lives of patients worldwide. — PolitiTweet.org

Governor Mike Parson @GovParsonMO

Today, we visited the @TevaUSA global headquarters in Israel and got to tour the SLE distribution facility. We le… https://t.co/YpclCud2Zg

Posted Nov. 14, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Live from #HLTH2022 — Our Sr. U.S. Medical Director, Respiratory and President of the @DHEHAlliance, Tanisha Hill, moderates a panel addressing digital determinants of health to improve access to care. https://t.co/zL2AHWlCRg — PolitiTweet.org

Posted Nov. 14, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Advancing #asthma care is important to us and exploring the potential of #digitalhealth solutions in asthma control is our north star in respiratory research. Thank you for joining us at #ACAAI22 to learn about our scientific progress in this area. — PolitiTweet.org

Posted Nov. 14, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

We’re excited to be a part of today’s #digitalhealth conversations. Come see us at #HLTH22 and learn about our latest collaborations advancing better data integration and predictive technologies. Learn more about this news here. https://t.co/6UtTVcGrAg https://t.co/XvGsrcvMvW — PolitiTweet.org

Posted Nov. 14, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

We’re excited to be a part of today’s #digitalhealth conversations. Come see us at #HLTH22 and learn about our latest collaborations advancing better data integration and predictive technologies. Learn more about this news here. https://t.co/6UtTVcGrAg https://t.co/fVMrQoqVDM — PolitiTweet.org

Posted Nov. 14, 2022 Just a Typo
Profile Image

Teva Pharmaceuticals @TevaUSA

Calling all #HLTH22 attendees — Join Teva’s Head of Digital Health and Innovation, Manny Montalvo, on the panel: Digital Therapeutics, Playing the Long Game. You won’t want to miss this! Join us at The Arena Stage on Nov. 14 at 3:30pm PST. — PolitiTweet.org

Posted Nov. 13, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Shachaf Reingewirtz is a chemist in the Quality Control lab at Teva’s manufacturing site in Kfar Saba, Israel. She ensures the high quality of Teva medications before they reach patients like Jaime, who has been suffering from chronic migraine. Watch here: https://t.co/lThztLm25u https://t.co/jsHQtHUaer — PolitiTweet.org

Posted Nov. 11, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Today at #ACAAI22 we’re proud to share our latest discoveries in #asthma management and the role #digitalhealth tools could play in treatment discussions. — PolitiTweet.org

Posted Nov. 11, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Proud to join Energize, a collaborative effort by the pharma industry and @SESustainable to increase access to renewable electricity for our suppliers. We’re committed to making a difference in our ESG journey. #Energize #COP27 #ClimateAction #RenewableEnergy — PolitiTweet.org

Schneider Electric Sustainability Business @SESustainable

We are thrilled to announce the #Energize pharmaceutical supply chain renewable energy program has formed its first… https://t.co/BqArInnGDx

Posted Nov. 11, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Honored to be invited by the Israeli government delegation to represent Israel at the #COP27 conference yesterday where Amalia Adler Waxman, our Global Head of ESG, shared Teva's #ESG approach and the progress we are making. Read more:https://t.co/WmsBVEpdqi****** #ClimateAction https://t.co/mhripc1UAk — PolitiTweet.org

Posted Nov. 10, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

We are grateful to team Teva for coming together with key decisionmakers across the industry to improve patient access to high-quality medicines. — PolitiTweet.org

Posted Nov. 10, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Our policy and regulatory team members were out in full force at @AccessibleMeds #GRxBiosims this week to help shape the future of the generics and biosimilars industry. https://t.co/WAAgae41oq — PolitiTweet.org

Posted Nov. 10, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

We need better regulatory guidance and pathways for complex generics, notes Teva’s Janet Vaughn at @AccessibleMeds #GRxBiosims. It’s critical that FDA foster the development of complex generics in order to improve patient access. https://t.co/MXulXO9BKN — PolitiTweet.org

Posted Nov. 9, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Teva’s Janet Vaughn will be on stage soon @GRxBiosims to highlight regulatory barriers and opportunities for improvement within the complex generics space. https://t.co/OtN3p6UHjO — PolitiTweet.org

Posted Nov. 9, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

The passage of #BsUFA III showcases forward-thinking goals aimed at bringing biosimilars to market faster, improving patient access, and delivering savings across the system – Teva’s Cory Wohlbach states, live @AccessibleMeds #GRxBiosims https://t.co/e6GSbDpkR6 — PolitiTweet.org

Posted Nov. 9, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Cory Wohlbach is back onstage today at #GRxBiosims breaking down the Biosimilar User Fee Act (BsUFA III), recently reauthorized by Congress. Cory is shedding light on FDA’s new regulatory science pilot program aimed at advancing biosimilar products. https://t.co/AGjuOBAWi3 — PolitiTweet.org

Posted Nov. 9, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Christine Baeder, SVP, COO for US Generics at Teva and AAM Vice Chair shares a recap of the exciting happenings at #GRxBiosims 2022. She sat down with AAM to discuss the regulatory environment and the need for collaboration to pave the way for complex generics and biosimilars. — PolitiTweet.org

AAM @AccessibleMeds

"It's an exciting time to gather at GRx+Biosims 2022. No one mind can solve our problems, it really takes people co… https://t.co/XKoTv2Oh8U

Posted Nov. 9, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

What does the future of digital healthcare look like? What determines the success and value of a digital therapy? Join Teva’s Manny Montalvo at #HLTH22 for a panel discussion discussing the role Teva aims to play in transforming the next decade of healthcare. — PolitiTweet.org

Posted Nov. 9, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

There are many hurdles in biosimilar development, yet it’s critically important for the industry to forge ahead this critical category, says Teva’s Cory Wohlbach at #GRxBiosims. Biosimilars can help bring affordable medicines to patients and savings to the US healthcare system. https://t.co/THM4KT0uSP — PolitiTweet.org

Posted Nov. 8, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

Legislation to improve therapeutic equivalence rating determination to drive access to complex generics was one of the many critical fixes left out of the UFA package, Teva’s Brian McCormick notes at #GRxBiosims https://t.co/I42TZTBhWX — PolitiTweet.org

Posted Nov. 8, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

RT @cecelou18: @US_FDA One of industry’s concerns with the IRA is ensuring “the continued incentives and growth of the generic and the bios… — PolitiTweet.org

Posted Nov. 8, 2022 Retweet
Profile Image

Teva Pharmaceuticals @TevaUSA

Teva’s Cory Wohlbach is about to take the stage at #GRxBiosims to talk regulatory improvements that FDA can make to streamline biosimilar development and approval. https://t.co/ugcQZ0Li93 — PolitiTweet.org

Posted Nov. 8, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

The FDA User Fee Amendments passed as a clean bill and many important policy riders were excluded. Teva’s own Brian McCormick will soon break down UFA, what was left out, and what this means for patients at @AccessibleMeds #GrXBiosims. https://t.co/X42Gt4Ac8U — PolitiTweet.org

Posted Nov. 8, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

We’re attending the American College of Asthma, Allergy and Immunology 2022 Annual Scientific Meeting to present 6️⃣ posters highlighting our latest data from the CONNECT1 and CONNECT2 trials in #asthma management. #ACAAI22 @ACAAI #digitalhealth — PolitiTweet.org

Posted Nov. 7, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

The current regulatory framework for biosimilars and determining interchangeability within the US is not sustainable. @RachelTurow is live at #GRxBiosims discussing how we can break down unnecessary barriers and drive uptake– with savings to patients and the US healthcare system. https://t.co/mcpSJQYNiX — PolitiTweet.org

Posted Nov. 7, 2022
Profile Image

Teva Pharmaceuticals @TevaUSA

The passage of #GDUFA III signals a step in the right direction for generic access for patients and increasing competition for industry members while improving the overall healthcare infrastructure – Teva’s Brian McCormick remarked @AccessibleMeds #GRxBiosims https://t.co/8FDXWoikxz — PolitiTweet.org

Posted Nov. 7, 2022